Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
CRISPR J ; 5(1): 155-164, 2022 02.
Article in English | MEDLINE | ID: mdl-35191751

ABSTRACT

Functional characterization of the multitude of poorly described proteins in the human malarial pathogen, Plasmodium falciparum, requires tools to enable genome-scale perturbation studies. Here, we present GeneTargeter (genetargeter.mit.edu), a software tool for automating the design of homology-directed repair donor vectors to achieve gene knockouts, conditional knockdowns, and epitope tagging of P. falciparum genes. We demonstrate GeneTargeter-facilitated genome-scale design of six different types of knockout and conditional knockdown constructs for the P. falciparum genome and validate the computational design process experimentally with successful donor vector assembly and transfection. The software's modular nature accommodates arbitrary destination vectors and allows customizable designs that extend the genome manipulation outcomes attainable in Plasmodium and other organisms.


Subject(s)
Malaria, Falciparum , Parasites , Animals , CRISPR-Cas Systems/genetics , Gene Editing , Humans , Malaria, Falciparum/genetics , Malaria, Falciparum/parasitology , Parasites/genetics , Plasmodium falciparum/genetics
2.
PLoS Genet ; 10(7): e1004490, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25032964

ABSTRACT

SIRT1 is a metabolic sensor and regulator in various mammalian tissues and functions to counteract metabolic and age-related diseases. Here we generated and analyzed mice that express SIRT1 at high levels specifically in skeletal muscle. We show that SIRT1 transgenic muscle exhibits a fiber shift from fast-to-slow twitch, increased levels of PGC-1α, markers of oxidative metabolism and mitochondrial biogenesis, and decreased expression of the atrophy gene program. To examine whether increased activity of SIRT1 protects from muscular dystrophy, a muscle degenerative disease, we crossed SIRT1 muscle transgenic mice to mdx mice, a genetic model of Duchenne muscular dystrophy. SIRT1 overexpression in muscle reverses the phenotype of mdx mice, as determined by histology, creatine kinase release into the blood, and endurance in treadmill exercise. In addition, SIRT1 overexpression also results in increased levels of utrophin, a functional analogue of dystrophin, as well as increased expression of PGC-1α targets and neuromuscular junction genes. Based on these findings, we suggest that pharmacological interventions that activate SIRT1 in skeletal muscle might offer a new approach for treating muscle diseases.


Subject(s)
Dystrophin/genetics , Muscle, Skeletal/metabolism , Muscular Dystrophy, Duchenne/genetics , Sirtuin 1/biosynthesis , Animals , Disease Models, Animal , Dystrophin/metabolism , Gene Expression Regulation, Developmental , Mice , Mice, Inbred mdx , Muscle Fibers, Slow-Twitch/metabolism , Muscle Fibers, Slow-Twitch/pathology , Muscle, Skeletal/physiopathology , Muscular Dystrophy, Duchenne/physiopathology , Neuromuscular Junction/metabolism , Neuromuscular Junction/physiopathology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Sirtuin 1/genetics , Trans-Activators/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...